Generate a tailored SOP for Dr. Philip Trackman. Improve your application with a focused, well-structured draft.
Philip Trackman is an Emeritus Professor at Boston University, affiliated with the Henry M. Goldman School of Dental Medicine. With a PhD from Boston University, Trackman’s research has significantly contributed to the understanding of oral cancer and diabetic bone disease. He has been involved in the Oral Cancer Research Initiative, where he investigates the molecular mechanisms of the enzyme lysyl oxidase, particularly its potential therapeutic effects in oral cancer. Trackman's work includes exploring ways to inhibit harmful enzymatic activities related to tumor growth. His research has shown that lysyl oxidase has tumor inhibitory properties and has confirmed this in various animal models. Additionally, Trackman has held leadership roles in graduate programs and has contributed to numerous projects and grants aimed at advancing the understanding of cancer mechanisms and therapeutic possibilities. His academic career is marked by extensive collaboration and mentorship of graduate students, reinforcing his dedication to education and research.
Boston University Henry M. Goldman School of Dental Medicine • Boston, MA
Contributed to the field of translational dental medicine and oral cancer research.
Boston University • Boston, MA
Led graduate programs in the Department of Molecular & Cell Biology.
Department of Law offers JD, LLM, and Master's in Study of Tax Law.